Prestrelski Steven (CIK 0001744027)

Latest company ownership

XERS - Xeris Biopharma Holdings, Inc.
Role: Chief Scientific Officer
Shares held
719,780
Last filed at
Feb 1, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 22, 2022 Feb 24, 2022 Xeris Biopharma Holdings, Inc. Chief Scientific Officer Sell 48.8 -11,228 -1.93% ✓ $27.2K